Cell membrane-camouflaged PLGA biomimetic system for diverse biomedical application

References

• Alkaff SA, Radhakrishnan K, Nedumaran AM, et al. (2020). Nanocarriers for stroke therapy: advances and obstacles in translating animal studies. Int J Nanomed 15:445–64.
   PubMed Web of Science ®Google Scholar
• Allen C, Evans JC. (2020). ‘Hip to be square’: designing PLGA formulations for the future. J Control Release 319:487–8.
   PubMed Web of Science ®Google Scholar
• Altaf S, Muhammad F, Aslam B, et al. (2021). Cell membrane enveloped polymeric nanosponge for detoxification of chlorpyrifos poison: in vitro and in vivo studies. Hum Exp Toxicol 40:1286–95.
   PubMed Web of Science ®Google Scholar
• Angsantikul P, Thamphiwatana S, Zhang QZ, et al. (2018). Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori. Adv Therap 1:1800016.
   Web of Science ®Google Scholar
• Anwar M, Muhammad F, Akhtar B, et al. (2021). Outer membrane protein-coated nanoparticles as antibacterial vaccine candidates. Int J Pept Res Ther 27:1689–97.
   PubMed Web of Science ®Google Scholar
• Bose RJ, Lee S-H, Park H. (2016). Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications. Biomater Res 20:34.
   PubMedGoogle Scholar
• Bose RJC, Kim BJ, Arai Y, et al. (2018). Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia. Biomaterials 185:360–70.
   PubMed Web of Science ®Google Scholar
• Bradberry JC, Fagan SC, Gray DR, et al. (2004). New perspectives on the pharmacotherapy of ischemic stroke. J Am Pharm Assoc (2003) 44:S46–S56.
   PubMedGoogle Scholar
• Cai JX, Liu JH, Wu JY, et al. (2022). Hybrid cell membrane-functionalized biomimetic nanoparticles for targeted therapy of osteosarcoma. Int J Nanomedicine 17:837–54.
   PubMed Web of Science ®Google Scholar
• Chen HY, Deng J, Wang Y, et al. (2020a). Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater 112:1–13.
   PubMed Web of Science ®Google Scholar
• Chen S, Ren YJ, Duan P. (2020b). Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling. Biomed Pharmacother 129:110371.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen X, Han SL, et al. (2020c). Irradiation pretreatment enhances the therapeutic efficacy of platelet-membrane-camouflaged antitumor nanoparticles. J Nanobiotechnol 18:101.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao PF, Luo ZY, et al. (2016). Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. Acs Nano 10:10049–57.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Wang WT, Li YS, et al. (2021). Folic acid-modified erythrocyte membrane loading dual drug for targeted and chemo-photothermal synergistic cancer therapy. Mol Pharm 18:386–402.
   PubMed Web of Science ®Google Scholar
• Cui YX, Sun JJ, Hao WY, et al. (2020). Dual-target peptide-modified erythrocyte membrane-enveloped PLGA nanoparticles for the treatment of glioma. Front Oncol 10:563938.
   PubMed Web of Science ®Google Scholar
• Dash P, Piras AM, Dash M. (2020). Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy. J Control Release 327:546–70.
   PubMed Web of Science ®Google Scholar
• De La Harpe KM, Kondiah PPD, Choonara YE, et al. (2019). The hemocompatibility of nanoparticles: a review of cell-nanoparticle interactions and hemostasis. Cells 8:1209.
   PubMed Web of Science ®Google Scholar
• Dehaini D, Wei XL, Fang RH, et al. (2017). Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater 29:1606209.
   Web of Science ®Google Scholar
• Fan ZY, Li PY, Deng JJ, et al. (2018). Cell membrane coating for reducing nanoparticle-induced inflammatory responses to scaffold constructs. Nano Res 11:5573–83.
   PubMed Web of Science ®Google Scholar
• Fang RH, Kroll AV, Gao WW, et al. (2018). Cell membrane coating nanotechnology. Adv Mater 30:1706759.
   PubMed Web of Science ®Google Scholar
• Finkel Y, Mizrahi O, Nachshon A, et al. (2021). The coding capacity of SARS-CoV-2. Nature 589:125–30.
   PubMed Web of Science ®Google Scholar
• Fu AK, Yao BQ, Dong TT, et al. (2022). Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 185:1356–72.
   PubMed Web of Science ®Google Scholar
• Gao C, Huang QX, Liu CH, et al. (2020a). Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat Commun 11:2622.
   PubMed Web of Science ®Google Scholar
• Gao CH, Chu XY, Gong W, et al. (2020b). Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease. J Nanobiotechnol 18:71.
   PubMed Web of Science ®Google Scholar
• Gao M, Hu AY, Sun XQ, et al. (2017a). Photosensitizer decorated red blood cells as an ultrasensitive light responsive drug delivery system. ACS Appl Mater Interfaces 9:5855–63.
   PubMed Web of Science ®Google Scholar
• Gao M, Liang C, Song XJ, et al. (2017b). Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy. Adv Mater 29:1701429.
   Web of Science ®Google Scholar
• Gao Y, Zhu Y, Xu XP, et al. (2021). Surface PEGylated cancer cell membrane-coated nanoparticles for codelivery of curcumin and doxorubicin for the treatment of multidrug resistant esophageal carcinoma. Front Cell Dev Biol 9:688070.
   PubMed Web of Science ®Google Scholar
• Geng XR, Gao DY, Hu DH, et al. (2020). Active-targeting NIR-II phototheranostics in multiple tumor models using platelet-camouflaged nanoprobes. ACS Appl Mater Interfaces 12:55624–37.
   PubMed Web of Science ®Google Scholar
• Gimbrone MA, Garcia-Cardena G. (2016). Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 118:620–36.
   PubMed Web of Science ®Google Scholar
• Glinsky VV, Huflejt ME, Glinsky GV, et al. (2000). Effects of Thomsen–Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 60:2584–8.
   PubMed Web of Science ®Google Scholar
• Gong CA, Yu XY, You BM, et al. (2020). Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. J Nanobiotechnology 18:92.
   PubMed Web of Science ®Google Scholar
• Gou SS, Liu WW, Wang S, et al. (2021). Engineered nanovaccine targeting Clec9a(+) dendritic cells remarkably enhances the cancer immunotherapy effects of STING agonist. Nano Lett 21:9939–50.
   PubMed Web of Science ®Google Scholar
• Guo K, Liu YX, Tang LR, et al. (2022). Homotypic biomimetic coating synergizes chemo-photothermal combination therapy to treat breast cancer overcoming drug resistance. Chem Eng J 428:131120.
   Web of Science ®Google Scholar
• Han SL, Wang WJ, Wang SF, et al. (2019). Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages. Nanoscale 11:20206–20.
   PubMed Web of Science ®Google Scholar
• Han ZW, Lv WX, Li YK, et al. (2020). Improving tumor targeting of exosomal membrane-coated polymeric nanoparticles by conjugation with aptamers. ACS Appl Bio Mater 3:2666–73.
   PubMedGoogle Scholar
• Hao XF, Li Q, Wang HN, et al. (2018). Red-blood-cell-mimetic gene delivery systems for long circulation and high transfection efficiency in ECs. J Mater Chem B 6:5975–85.
   PubMed Web of Science ®Google Scholar
• He YW, Li RX, Liang JM, et al. (2018). Drug targeting through platelet membrane-coated nanoparticles for the treatment of rheumatoid arthritis. Nano Res 11:6086–101.
   Web of Science ®Google Scholar
• Hendriksen C, Kreiner S, Binder V. (1985). Long term prognosis in ulcerative colitis based on results from a regional patient group from the county of Copenhagen. Gut 26:158–63.
   PubMed Web of Science ®Google Scholar
• Hodgkinson CP, Bareja A, Gomez JA, et al. (2016). Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circ Res 118:95–107.
   PubMed Web of Science ®Google Scholar
• Hu C, Lei T, Wang Y, et al. (2020). Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity. Biomaterials 255:120159.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Fang RH, Wang KC, et al. (2015). Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526:118–21.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 108:10980–5.
   PubMed Web of Science ®Google Scholar
• Hu YL, Fu YH, Tabata Y, et al. (2010). Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. J Control Release 147:154–62.
   PubMed Web of Science ®Google Scholar
• Huang X, Shen A, Peng R, et al. (2021). A novel biomimetic nanoprobe as a photoacoustic contrast agent. Front Chem 9:721799.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang B, Zhang L, et al. (2018). Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma. Artif Cells Nanomed Biotechnol 46:1088–101.
   PubMed Web of Science ®Google Scholar
• Jin JF, Krishnamachary B, Barnett JD, et al. (2019). Human cancer cell membrane-coated biomimetic nanoparticles reduce fibroblast-mediated invasion and metastasis and induce T-cells. ACS Appl Mater Interfaces 11:7850–61.
   PubMed Web of Science ®Google Scholar
• Jin K, Luo ZM, Zhang B, et al. (2018). Biomimetic nanoparticles for inflammation targeting. Acta Pharm Sin B 8:23–33.
   PubMed Web of Science ®Google Scholar
• Kang M, Hong J, Jung M, et al. (2020). T-cell-mimicking nanoparticles for cancer immunotherapy. Adv Mater 32:2003368.
   Web of Science ®Google Scholar
• Karin M, Clevers H. (2016). Reparative inflammation takes charge of tissue regeneration. Nature 529:307–15.
   PubMed Web of Science ®Google Scholar
• Kola SM, Choonara YE, Kumar P, et al. (2021). Platelet-inspired therapeutics: current status, limitations, clinical implications, and future potential. Drug Deliv Transl Res 11:24–48.
   PubMed Web of Science ®Google Scholar
• Kondo K, Kohno N, Yokoyama A, et al. (1998). Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res 58:2014–9.
   PubMed Web of Science ®Google Scholar
• Kumar P, V, TreurenT, Ranjan AP, et al. (2019). In vivo imaging and biodistribution of near infrared dye loaded brain-metastatic-breast-cancer-cell-membrane coated polymeric nanoparticles. Nanotechnology 30:265101.
   PubMed Web of Science ®Google Scholar
• Kunde SS, Wairkar S. (2021). Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy. Int J Pharm 598:120395.
   PubMed Web of Science ®Google Scholar
• Le QV, Lee J, Lee H, et al. (2021). Cell membrane-derived vesicles for delivery of therapeutic agents. Acta Pharm Sin B 11:2096–113.
   PubMed Web of Science ®Google Scholar
• Lesterhuis WJ, Haanen J, Punt CJA. (2011). Cancer immunotherapy - revisited. Nat Rev Drug Discov 10:591–600.
   PubMed Web of Science ®Google Scholar
• Li L, Fu J, Wang XY, et al. (2021a). Biomimetic "nanoplatelets" as a targeted drug delivery platform for breast cancer theranostics. ACS Appl Mater Interfaces 13:3605–21.
   PubMed Web of Science ®Google Scholar
• Li MJ, Xu ZJ, Zhang L, et al. (2021b). Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles. Acs Nano 15:9808–19.
   PubMed Web of Science ®Google Scholar
• Li S, Jiang WP, Yuan YP, et al. (2020). Delicately designed cancer cell membrane-camouflaged nanoparticles for targeted F-19 MR/PA/FL imaging-guided photothermal therapy. ACS Appl Mater Interfaces 12:57290–301.
   PubMed Web of Science ®Google Scholar
• Li YY, Che JY, Chang L, et al. (2022). CD47-and integrin alpha 4/beta 1-comodified-macrophage-membrane-coated nanoparticles enable delivery of colchicine to atherosclerotic plaque. Adv Healthcare Mater 11:2101788.
   Web of Science ®Google Scholar
• Li ZS, Zhang XY, Liu C, et al. (2021c). Macrophage-biomimetic nanoparticles ameliorate ulcerative colitis through reducing inflammatory factors expression. J Innate Immun 14:380–92.
   PubMed Web of Science ®Google Scholar
• Liang N, Ren N, Feng ZC, et al. (2022). Biomimetic metal-organic frameworks as targeted vehicles to enhance osteogenesis. Adv Healthc Mater 11:e2102821.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang W, Li YK, et al. (2019). Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting. Nano Lett 19:7836–44.
   PubMed Web of Science ®Google Scholar
• Liu LQ, Wang Y, Guo X, et al. (2020a). A biomimetic polymer magnetic nanocarrier polarizing tumor-associated macrophages for potentiating immunotherapy. Small 16:2003543.
   PubMed Web of Science ®Google Scholar
• Liu R, An Y, Jia W, et al. (2020b). Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer. J Control Release 321:589–601.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhong X, Li C. (2021). Challenges in cell membrane-camouflaged drug delivery systems: development strategies and future prospects. Chin Chem Lett 32:2347–58.
   Web of Science ®Google Scholar
• Liu YF, Wen NC, Li K, et al. (2022). Photolytic removal of red blood cell membranes camouflaged on nanoparticles for enhanced cellular uptake and combined chemo-photodynamic inhibition of cancer cells. Mol Pharm 19:805–18.
   PubMed Web of Science ®Google Scholar
• Luk BT, Fang RH, Hu CMJ, et al. (2016). Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics 6:1004–11.
   PubMed Web of Science ®Google Scholar
• Luk BT, Hu CMJ, Fang RNH, et al. (2014). Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6:2730–7.
   PubMed Web of Science ®Google Scholar
• Luo L, Tang JN, Nishi K, et al. (2017). Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in mice. Circ Res 120:1768–75.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang S, Liu J, et al. (2019). Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells. Small 15:1902011.
   PubMed Web of Science ®Google Scholar
• Ma JN, Liu FY, Sheu WC, et al. (2020). Copresentation of tumor antigens and costimulatory molecules via biomimetic nanoparticles for effective cancer immunotherapy. Nano Lett 20:4084–94.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377–97.
   PubMed Web of Science ®Google Scholar
• Mao Y, Zou C, Jiang Y, et al. (2021). Erythrocyte-derived drug delivery systems in cancer therapy. Chin Chem Lett 32:990–8.
   Web of Science ®Google Scholar
• Mi Y, Hagan CT, Vincent BG, et al. (2019). Emerging nano-/microapproaches for cancer immunotherapy. Adv Sci (Weinh) 6:1801847.
   PubMedGoogle Scholar
• Moore JB, June CH. (2020). Cytokine release syndrome in severe COVID-19. Science 368:473–4.
   PubMed Web of Science ®Google Scholar
• Morgan RA, Dudley ME, Wunderlich JR, et al. (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126–9.
   PubMed Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003.
   PubMed Web of Science ®Google Scholar
• Nakki S, Martinez JO, Evangelopoulos M, et al. (2017). Chlorin e6 functionalized theranostic multistage nanovectors transported by stem cells for effective photodynamic therapy. ACS Appl Mater Interfaces 9:23441–9.
   PubMed Web of Science ®Google Scholar
• Neurath MF. (2017). Current and emerging therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol 14:269–78.
   PubMed Web of Science ®Google Scholar
• Nitzsche F, Muller C, Lukomska B, et al. (2017). Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells 35:1446–60.
   PubMed Web of Science ®Google Scholar
• Oldenborg PA, Zheleznyak A, Fang YF, et al. (2000). Role of CD47 as a marker of self on red blood cells. Science 288:2051–4.
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Beygi M, Baradaran B, et al. (2021). Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small 17:2006484.
   PubMed Web of Science ®Google Scholar
• Pandita D, Kumar S, Lather V. (2015). Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives. Drug Discov Today 20:95–104.
   PubMed Web of Science ®Google Scholar
• Park K, Skidmore S, Hadar J, et al. (2019). Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation. J Control Release 304:125–34.
   PubMed Web of Science ®Google Scholar
• Rao L, Xia S, Xu W, et al. (2020). Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci USA 117:27141–7.
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano JE, Freedman J. (2011). Platelets and the immune continuum. Nat Rev Immunol 11:264–74.
   PubMed Web of Science ®Google Scholar
• Shi Y, Xie FF, Rao PS, et al. (2020). TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. J Control Release 320:304–13.
   PubMed Web of Science ®Google Scholar
• Shi YS, Lin G, Zheng HL, et al. (2021). Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly. J Nanobiotechnology 19:447.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Mcinnes IB. (2016). Rheumatoid arthritis. Lancet 388:2023–38.
   PubMed Web of Science ®Google Scholar
• Song RY, Peng C, Xu XN, et al. (2018). Controllable formation of monodisperse polymer microbubbles as ultrasound contrast agents. ACS Appl Mater Interfaces 10:14312–20.
   PubMed Web of Science ®Google Scholar
• Sun KJ, Yu WJ, Ji B, et al. (2020a). Saikosaponin D loaded macrophage membrane-biomimetic nanoparticles target angiogenic signaling for breast cancer therapy. Appl Mater Today 18:100505.
   Web of Science ®Google Scholar
• Sun X, He GH, Xiong CX, et al. (2021). One-pot fabrication of hollow porphyrinic MOF nanoparticles with ultrahigh drug loading toward controlled delivery and synergistic cancer therapy. ACS Appl Mater Interfaces 13:3679–93.
   PubMed Web of Science ®Google Scholar
• Sun YX, Zhai WH, Liu XJ, et al. (2020b). Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma. J Nanobiotechnol 18:60.
   PubMed Web of Science ®Google Scholar
• Swider E, Koshkina O, Tel J, et al. (2018). Customizing poly(lactic-co-glycolic acid) particles for biomedical applications. Acta Biomater 73:38–51.
   PubMed Web of Science ®Google Scholar
• Tan QQ, He LJ, Meng XJ, et al. (2021). Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J Nanobiotechnol 19:173.
   PubMed Web of Science ®Google Scholar
• Tang CM, Wang QQ, Li KM, et al. (2021). A neutrophil-mimetic magnetic nanoprobe for molecular magnetic resonance imaging of stroke-induced neuroinflammation. Biomater Sci 9:5247–58.
   PubMed Web of Science ®Google Scholar
• Tang JA, Shen DL, Caranasos TG, et al. (2017). Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun 8:13724.
   PubMed Web of Science ®Google Scholar
• Thamphiwatana S, Angsantikul P, Escajadillo T, et al. (2017). Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management. Proc Natl Acad Sci USA 114:11488–93.
   PubMed Web of Science ®Google Scholar
• Thi TTH, Pilkington EH, Nguyen DH, et al. (2020). The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation. Polymers 12:298.
   PubMed Web of Science ®Google Scholar
• Tian H, Luo ZY, Liu LL, et al. (2017). Cancer cell membrane-biomimetic oxygen nanocarrier for breaking hypoxia-induced chemoresistance. Adv Funct Mater 27:1703197.
   Web of Science ®Google Scholar
• Wang HJ, Wu JZ, Williams GR, et al. (2019a). Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery. J Nanobiotechnol 17:60.
   PubMed Web of Science ®Google Scholar
• Wang M, Hu QD, Huang JM, et al. (2022a). Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy. J Nanobiotechnol 20:85.
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng H, Peng HS, et al. (2015). Non-genetic engineering of cells for drug delivery and cell-based therapy. Adv Drug Deliv Rev 91:125–40.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang K, Li TH, et al. (2021). Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics 11:164–80.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang K, Qin X, et al. (2019b). Biomimetic nanotherapies: red blood cell based core-shell structured nanocomplexes for atherosclerosis management. Adv Sci (Weinh) 6:1900172.
   PubMedGoogle Scholar
• Wang Y, Zhang L, Zhao GS, et al. (2022b). Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms. J Nanobiotechnol 20:83.
   PubMed Web of Science ®Google Scholar
• Wang YC, Luan ZY, Zhao CY, et al. (2020). Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy. Eur J Pharm Sci 142:105136.
   PubMed Web of Science ®Google Scholar
• Wang YQ, Liu ZY, Wang H, et al. (2019c). Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory. Acta Biomater 92:241–53.
   PubMed Web of Science ®Google Scholar
• Wei XL, Gao J, Fang RH, et al. (2016). Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials 111:116–23.
   PubMed Web of Science ®Google Scholar
• Wei XL, Ying M, Dehaini D, et al. (2018). Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis. Acs Nano 12:109–16.
   PubMed Web of Science ®Google Scholar
• Wu H, Jiang X, Li Y, et al. (2020). Engineering stem cell derived biomimetic vesicles for versatility and effective targeted delivery. Adv Funct Mater 30:2006169.
   Web of Science ®Google Scholar
• Wu HH, Zhou Y, Tabata Y, et al. (2019a). Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. J Control Release 294:102–13.
   PubMed Web of Science ®Google Scholar
• Wu PY, Yin DT, Liu JM, et al. (2019b). Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer. Nanoscale 11:19520–8.
   PubMed Web of Science ®Google Scholar
• Wu XY, Li YC, Raza F, et al. (2021). Red blood cell membrane-camouflaged tedizolid phosphate-loaded PLGA nanoparticles for bacterial-infection therapy. Pharmaceutics 13:99.
   PubMed Web of Science ®Google Scholar
• Xiao L, Huang Y, Yang YH, et al. (2021). Biomimetic cytomembrane nanovaccines prevent breast cancer development in the long term. Nanoscale 13:3594–601.
   PubMed Web of Science ®Google Scholar
• Xie XT, Wang HJ, Williams GR, et al. (2019). Erythrocyte membrane cloaked curcumin-loaded nanoparticles for enhanced chemotherapy. Pharmaceutics 11:429.
   PubMed Web of Science ®Google Scholar
• Xiong X, Zhao JY, Su R, et al. (2021). Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy. Nano Today 39:101225.
   Web of Science ®Google Scholar
• Xu C, Liu W, Hu Y, et al. (2020). Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Theranostics 10:3325–39.
   PubMed Web of Science ®Google Scholar
• Xu HG, Wang B, Ono M, et al. (2019). Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24:566–78.
   PubMed Web of Science ®Google Scholar
• Xu LL, Chen YH, Jin QF, et al. (2021). Biomimetic PLGA microbubbles coated with platelet membranes for early detection of myocardial ischaemia-reperfusion injury. Mol Pharm 18:2974–85.
   PubMed Web of Science ®Google Scholar
• Yaman S, Ramachandramoorthy H, Oter G, et al. (2020). Melanoma peptide MHC specific TCR expressing T-cell membrane camouflaged PLGA nanoparticles for treatment of melanoma skin cancer. Front Bioeng Biotechnol 8:943:943.
   PubMed Web of Science ®Google Scholar
• Yang L, Zang GC, Li JW, et al. (2020). Cell-derived biomimetic nanoparticles as a novel drug delivery system for atherosclerosis: predecessors and perspectives. Regen Biomater 7:349–58.
   PubMed Web of Science ®Google Scholar
• Yang N, Ding YP, Zhang YL, et al. (2018). Surface functionalization of polymeric nanoparticles with umbilical cord-derived mesenchymal stem cell membrane for tumor-targeted therapy. ACS Appl Mater Interfaces 10:22963–73.
   PubMed Web of Science ®Google Scholar
• Yaroustovsky M, Plyushch M, Popov D, et al. (2013). Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery. J Inflamm 10:8.
   Google Scholar
• Ye H, Wang KY, Lu Q, et al. (2020). Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition. Biomaterials 242:119932.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang W, Zhu DS, et al. (2022a). Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy. J Nanobiotechnol 20:35.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao W, Huang JK, et al. (2022b). Development of a dendritic cell/tumor cell fusion cell membrane nano-vaccine for the treatment of ovarian cancer. Front Immunol 13:828263.
   PubMed Web of Science ®Google Scholar
• Zhang QZ, Dehaini D, Zhang Y, et al. (2018a). Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol 13:1182–90.
   PubMed Web of Science ®Google Scholar
• Zhang QZ, Honko A, Zhou JR, et al. (2020a). Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett 20:5570–4.
   PubMed Web of Science ®Google Scholar
• Zhang XM, Ai FY, Li XY, et al. (2015). Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis. Int J Cancer 137:2803–14.
   PubMed Web of Science ®Google Scholar
• Zhang YT, He ZH, Li YY, et al. (2021). Tumor cell membrane-derived nano-Trojan horses encapsulating phototherapy and chemotherapy are accepted by homologous tumor cells. Mater Sci Eng C Mater Biol Appl 120:111670.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian HQ, Huang J, et al. (2018b). Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int J Nanomedicine 13:4961–75.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian HQ, Yang M, et al. (2017). Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment. Int J Nanomedicine 12:1593–605.
   PubMed Web of Science ®Google Scholar
• Zhang ZQ, Li D, Li XH, et al. (2020b). PEI-modified macrophage cell membrane-coated PLGA nanoparticles encapsulating Dendrobium polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses. Int J Biol Macromol 165:239–48.
   PubMed Web of Science ®Google Scholar
• Zheng XL, Huang YZ, Zheng CH, et al. (2010). Alginate-chitosan-PLGA composite microspheres enabling single-shot hepatitis B vaccination. AAPS J 12:519–24.
   PubMed Web of Science ®Google Scholar
• Zheng XL, Zhu Y, Fei WD, et al. (2022). Redox-responsive and electrically neutral PLGA nanoparticles for siRna delivery in human cervical carcinoma cells. J Pharm Innov.
   Web of Science ®Google Scholar
• Zhong SS, Li LX, Shen X, et al. (2019). An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic Biol Med 144:266–78.
   PubMed Web of Science ®Google Scholar
• Zhou H, Fan ZY, Lemons PK, et al. (2016). A facile approach to functionalize cell membrane-coated nanoparticles. Theranostics 6:1012–22.
   PubMed Web of Science ®Google Scholar
• Zhu JH, Qin FH, Ji ZH, et al. (2019). Mannose-modified PLGA nanoparticles for sustained and targeted delivery in hepatitis B virus immunoprophylaxis. AAPS Pharmscitech 21:13.
   PubMed Web of Science ®Google Scholar
• Zuo H, Qiang J, Wang Y, et al. (2022). Design of red blood cell membrane-cloaked dihydroartemisinin nanoparticles with enhanced antimalarial efficacy. Int J Pharm 618:121665.
   PubMed Web of Science ®Google Scholar